Companies / Genomic Vision
Genomic Vision
France
Genomic Vision develops proprietary technology for bioproduction, gene and cell therapy, and the discovery of new molecules
Genomic Vision, based in France, has 1 investor on file, among them Vesalius Biocapital Partners. Its site was last checked 6 Nov 2026: site answers.
Investors
1 investor on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Venture capital |
More from Vesalius Biocapital Partners
10 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (90%), Food & Agriculture (10%).
See Vesalius Biocapital Partners' full profile · Who invests alongside it
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get Genomic Vision and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Vesalius Biocapital Partners adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/genomicvision.com/investors
# also
GET /v1/companies/genomicvision.com
GET /v1/companies/genomicvision.com/news